Cite
MLA Citation
Courtney Nichols et al.. “535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab.” Open forum infectious diseases, vol. 8, n.d., p. S369. http://access.bl.uk/ark:/81055/vdc_100150541948.0x000005